Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Proper

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Biometrics|April 8, 2022
An alternative metric for evaluating the potential patient benefit of response-adaptive randomization proceduresJennifer Proper, Thomas A Murray
Clinical Trials (London, England)|April 30, 2021
Alternative models and randomization techniques for Bayesian response-adaptive randomization with binary outcomesJennifer Proper, John Connett, Thomas Murray
Critical Care Medicine|May 25, 2022
The authors replyRonald A Reilkoff, Jennifer Proper, David A Wacker
Surgical Infections|January 29, 2024
Acute Appendicitis Treatment Strategies and Mortality Based on Critical Illness on Admission: An Observational StudySamantha King, Jennifer Proper, Lianne K Siegel, et al.
Plos One|April 2, 2021
Metabolite profiles associated with disease progression in influenza infectionChris H Wendt, Sandra Castro-Pearson, Jennifer Proper, et al.
American Journal of Clinical Dermatology|July 15, 2025
Efficacy and Safety of Lebrikizumab in Adult and Adolescent Patients with Skin of Color and Moderate-to-Severe Atopic Dermatitis: Results from the Phase IIIb, Open-Label ADmirable StudyAndrew Alexis, Ali Moiin, Jill Waibel, et al.
Surgical Infections|June 15, 2021
Morbidity and Mortality Trends of Pancreatitis: An Observational StudyNicholas E Ingraham, Samantha King, Jennifer Proper, et al.
Medrxiv : the Preprint Server for Health Sciences|September 30, 2020
Characterizing COVID-19 Clinical Phenotypes and Associated Comorbidities and Complication ProfilesElizabeth R Lusczek, Nicholas E Ingraham, Basil Karam, et al.
Plos One|March 31, 2021
Characterizing COVID-19 clinical phenotypes and associated comorbidities and complication profilesElizabeth R Lusczek, Nicholas E Ingraham, Basil S Karam, et al.
Dermatology and Therapy|January 19, 2026
Lebrikizumab Improves Clinical Manifestations, Symptoms, and Quality of Life in Patients with Moderate-to-Severe Atopic Dermatitis Previously Treated with Dupilumab: Results from the ADapt StudyJonathan I Silverberg, Lindsay Ackerman, Jerry Bagel, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Biometrics|April 8, 2022
An alternative metric for evaluating the potential patient benefit of response-adaptive randomization proceduresJennifer Proper, Thomas A Murray
Clinical Trials (London, England)|April 30, 2021
Alternative models and randomization techniques for Bayesian response-adaptive randomization with binary outcomesJennifer Proper, John Connett, Thomas Murray
Critical Care Medicine|May 25, 2022
The authors replyRonald A Reilkoff, Jennifer Proper, David A Wacker
Surgical Infections|January 29, 2024
Acute Appendicitis Treatment Strategies and Mortality Based on Critical Illness on Admission: An Observational StudySamantha King, Jennifer Proper, Lianne K Siegel, et al.
Plos One|April 2, 2021
Metabolite profiles associated with disease progression in influenza infectionChris H Wendt, Sandra Castro-Pearson, Jennifer Proper, et al.
American Journal of Clinical Dermatology|July 15, 2025
Efficacy and Safety of Lebrikizumab in Adult and Adolescent Patients with Skin of Color and Moderate-to-Severe Atopic Dermatitis: Results from the Phase IIIb, Open-Label ADmirable StudyAndrew Alexis, Ali Moiin, Jill Waibel, et al.
Surgical Infections|June 15, 2021
Morbidity and Mortality Trends of Pancreatitis: An Observational StudyNicholas E Ingraham, Samantha King, Jennifer Proper, et al.
Medrxiv : the Preprint Server for Health Sciences|September 30, 2020
Characterizing COVID-19 Clinical Phenotypes and Associated Comorbidities and Complication ProfilesElizabeth R Lusczek, Nicholas E Ingraham, Basil Karam, et al.
Plos One|March 31, 2021
Characterizing COVID-19 clinical phenotypes and associated comorbidities and complication profilesElizabeth R Lusczek, Nicholas E Ingraham, Basil S Karam, et al.
Dermatology and Therapy|January 19, 2026
Lebrikizumab Improves Clinical Manifestations, Symptoms, and Quality of Life in Patients with Moderate-to-Severe Atopic Dermatitis Previously Treated with Dupilumab: Results from the ADapt StudyJonathan I Silverberg, Lindsay Ackerman, Jerry Bagel, et al.
Pageof 2